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Abstract
Background: The R6K replicon is one of the best studied bacterial plasmid replicons. Replication of the R6K
plasmid and derivatives harboring its g origin of replication (oriR6Kg) is dependent on the pir gene-encoded π
protein. Originally encoded by R6K, this protein is usually provided in trans in hosts engineered to support
replication of plasmids harboring oriR6Kg.I nEscherichia coli this is commonly achieved by chromosomal integration
of pir either via lysogenization with a lpir phage or homologous recombination at a pre-determined locus.
Findings: Current methods for construction of host strains for oriR6Kg-containing plasmids involve procedures that
do not allow selection for presence of the pir gene and require cumbersome and time-consuming screening steps.
In this study, we established a mini-Tn7-based method for rapid and reliable construction of pir
+ host strains. Using
a curable mini-Tn7 delivery plasmid, pir expressing derivatives of several commonly used E. coli cloning and
mobilizer strains were isolated using both the wild-type pir
+ gene as well as the copy-up pir-116 allele. In addition,
we isolated pir
+ and pir-116 expressing derivatives of a clinical isolate of Salmonella enterica serovar Typhimurium.
In both E. coli and S. enterica serovar Typhimurium, the presence of the pir
+ wild-type or pir-116 alleles allowed the
replication of oriR6Kg-containing plasmids.
Conclusions: A mini-Tn7 system was employed for rapid and reliable engineering of E. coli and S. enterica serovar
Typhimurium host strains for plasmids containing oriR6Kg. Since mini-Tn7 elements transpose in most, if not all,
Gram negative bacteria, we anticipate that with relatively minor modifications this newly established method will
for the first time allow engineering of other bacterial species to enable replication of plasmids with oriR6Kg.
Background
The g origin of replication of the broad-host-range plas-
mid R6K (oriR6Kg) has been used to construct condition-
ally replicative cloning and transposon delivery vectors
too numerous to cite them all, with some of the most
well-known vectors described in the late 1980s and early
1990s [1-6]. Replication of these vectors requires the π
protein encoded by the pir gene which on R6K is
located next to the g origin of replication [7,8]. For
maintenance of conditionally replicative plasmids that
contain oriR6Kg but lack pir,t h eπ protein is expressed
in trans from pir located on a compatible plasmid or,
most frequently, on a l phage or a gene inserted into
the chromosome via homologous recombination at a
predetermined locus [9]. In cells harboring a wild-type
pir
+ gene, oriR6Kg containing plasmids are maintained at
15 copies or less depending on size of the oriR6Kg plas-
mid and pir gene source. A number of pir mutations
have been identified that alter plasmid copy number, for
example the pir-116 allele [10]. In cells harboring this
allele integrated into the chromosome, oriR6Kg plasmids
are maintained at a copy number of about 250 per cell
which compares to 15 copies per cell when the pir
+
allele is integrated at the same chromosomal locus [9].
The host range for oriR6Kg-containing plasmids is limited
because construction of strains supporting their
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for presence of the pir gene and require cumbersome
and time-consuming screening steps. To allow expan-
sion of plasmid host range to customized genetic strain
backgrounds we therefore developed a mini-Tn7-based
method for rapid and reliable construction of enterobac-
terial pir
+ host strains.
Results and discussion
Development of a mini-Tn7 based oriR6Kg chromosomal
insertion system
We sought to employ the mini-Tn7 method described
by McKenzie and Craig [11] for chromosomal insertion
of pir alleles in the absence of selection. For this pur-
pose, the pir
+ and pir-116 genes were cloned into the
mini-Tn7 delivery vector pGRG36 (Figure 1) and pub-
lished procedures [11] followed in an attempt to trans-
pose the cloned pir genes into the chromosomes of
various E. coli strains. However, in some strains, despite
repetition and exhaustive PCR screening, this method
proved ineffective for this purpose as the majority of
colonies obtained after completion of the procedure did
not contain the desired mini-Tn7 insertions or did not
result in any insertions, for unexplained reasons. We
therefore designed a method that allows positive selec-
tion of strains containing chromosomally inserted pir
alleles (Figure 2). The rationale for this method is to
establish the delivery vector with a temperature-sensitive
replicon (ts), here pSC101orits, at permissive tempera-
ture (30°C), then introduce an oriR6Kg reporter plasmid
at 37°C, creating conditions at which the mini-Tn7
delivery vector is cured and replication of the reporter
plasmid is dependent on the presence of a chromoso-
mally-integrated pir gene. After verification of the
desired mini-Tn7-pir insertions the reporter plasmid is
then cured using sucrose counter-selection.
Mini-Tn7 insertion of pir genes in E. coli and S. enterica
serovar Typhimurium
Following the procedure outlined in Figure 2, we readily
obtained mini-Tn7-pir insertions in several commonly
used E. coli laboratory cloning and mobilizer strains–
DH5a, JM108, MC4100, SM10, RHO3–and a clinical S.
enterica serovar Typhimurium isolate. Exconjugants
examined by PCR contained the desired insertion, either
mini-Tn7-pir
+ or mini-Tn7-pir-116 (Figure 3A). The
plasmid copy number of pR6KT2 was greatly elevated in
pir-116-containing E. coli DH5a and S. enterica serovar
Typhimurium 14028S host strains when compared to the
same strains containing chromosomally inserted wild-
type pir
+ (Figure 3B). An alternative to employing an
oriR6Kg reporter plasmid is to use mini-Tn7-pir elements
that contain a Km
r selection marker that after verification
of desired inserts can be removed using Saccharomyces
cerevisiae Flp recombinase-mediated site-specific exci-
sion, followed by curing of the Flp recombinase expres-
sion plasmid. We have successfully used this strategy in
E. coli. Both strategies require equal time and effort.
Conclusions
We have developed simple and effective strategies for
engineering of pir expressing strains of Enterobacteriaceae.
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Figure 1 Maps of mini-Tn7 delivery vector and oriR6Kg reporter
plasmid. A) Map of pir
+ delivery vector pGRG36pir. Other versions
include pGRG36pir-116 which contains pir-116 in place of pir
+ and
pGRG36pir-116-FKm contains a FRT-flanked Km
r marker adjacent to
pir-116 as illustrated in the inset. B) Map of the oriR6Kg reporter
plasmid pR6KT2. Abbreviations: aacC1, aminoglycoside
acetyltransferase conferring gentamicin resistance; araC, encoding
the AraC regulator of expression from the E. coli arabinose operon
promoter PBAD; B1 and B2, attB1 and attB2 Gateway recombination
sites; bla, b-lactamase gene conferring ampicillin resistance; FRT, Flp
recombinase target site; L and R, Tn7 left and right ends; nptII,
neomycin phosphotransferase gene conferring kanamycin
resistance; oriR6Kg, R6K plasmid g replication origin; oriT, RP4 conjugal
transfer origin; pSC101ori ts, temperature-sensitive pSC101
replication origin; sacB, levansucrase-encoding gene; tnsABCD, genes
encoding the Tn7 site-specific transposition pathway; uidA,
glucuronidase-encoding gene.
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Page 2 of 7These strategies allow extension of the host range of
oriR6Kg containing plasmids to virtually any enterobacterial
strain, something that was, to date, only possible using
relatively cumbersome and time-consuming methods, e.g.
isolation of lpir lysogens or chromosomal insertion of
cloned pir alleles via site-specific recombination at a pre-
determined locus [9]. Mini-Tn7 elements insert at natu-
rally evolved attTn7 sites that are usually located in inter-
genic regions downstream of conserved glmS genes
[12-16]. This alleviates the need for selecting potential
insertion sites not affecting bacterial fitness when choosing
recombinant DNA strategies for pir allele insertion into a
bacterial genome. Since mini-Tn7 elements transpose in
most, if not all, Gram negative bacteria, we anticipate that
with relatively minor modifications this newly established
method will for the first time allow engineering of other
bacterial species to enable replication of plasmids with
oriR6Kg. As described, the procedure relies on availability of
ts replicons which may limit its applicability to bacteria
that can tolerate the non-permissive temperatures needed
Figure 2 Overview of steps involved in chromosomal mini-Tn7-
pir insertion. A) Introduce the mini-Tn7-pir
+ delivery vector by
conjugation. Select ampicillin resistant (Amp
r) colonies at 30°C to
establish the delivery vector. B) Grow Amp
r cells at 30°C in presence
of arabinose to induce the genes encoding the Tn7 site-specific
transposition pathway. C) Introduce the oriR6Kg reporter pR6KT2 by
conjugation and grow at 37°C in the presence of gentamicin (Gm)
to cure the mini-Tn7-pir
+ delivery vector and report integrants
based on pir-dependent replication of pR6KT2. Establish Gm
r and
Amp susceptible (Amp
s) phenotype. D) Cure pR6KT2 reporter
plasmid by plating on sucrose-containing medium. Verify Gm
s and
Amp
s phenotype, and confirm pir
+ integrants by PCR (using primer
pair 2372 and 2373 for E. coli or 2374 and 2375 for S. enterica
serovar Typhimurium). It must be noted that PCR-based insertion
site verification strategies are limited to bacteria for which sequence
information about the glmS flanking sequences is available.
Methods for identifying Tn7 insertion sites in bacteria for which
genome sequences are unknown have been described [12].
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Figure 3 PCR verification of mini-Tn7-pir insertion and plasmid
copy number. A) PCR verification of pir
+ and pir-116 mini-Tn7
insertions into attTn7 of E. coli DH5a. Colony PCR with primers 2372
and 2373 (see Figure 2 for relative priming site locations) was
conducted to confirm presence or absence of the mini-Tn7-pir
+ and
mini-Tn7-pir-116 insertions. The PCR reactions were analyzed by
agarose gel electrophoresis. Expected fragment sizes are 678 bp for
DH5a without a mini-Tn7 insertion and 2,539 bp for derivatives
containing mini-Tn7-pir
+ or mini-Tn7-pir-116 insertions. Lane M, Hi-Lo
molecular size ladder from Minnesota Molecular (Minneapolis, MN)
with the sizes of selected fragments indicated; Lane -, DH5a negative
control (no insertion). B) Demonstration of pR6KT2 copy number in
pir
+ and pir-116 containing E. coli and S. enterica serovar Typhimurium
strains. Plasmid DNA was purified from overnight cultures of E. coli
DH5a and S. enterica serovar Typhiumurium 14028S containing either
mini-Tn7-pir
+ or mini-Tn7-pir-116.A2 0μl aliquot of each preparation
was digested with HindIII to linearize the 5,953-bp plasmid and the
samples were analyzed by agarose gel electrophoresis. Lane M
contains the same molecular size ladder as shown in panel A and the
sizes of selected fragments are indicated.
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Page 3 of 7for plasmid curing. The methods described here were
developed for Enterobacteriaceae which, like most bac-
teria, can tolerate 37°C, a temperature at which most plas-
mids with ts replicons, including pSC101orits, are readily
cured. For bacteria with growth temperature optima less
than 37°C, the described strategy will not work and require
appropriate modifications, i.e. inclusion of different coun-
ter-selection markers, for example sacB [17]. Lastly,
though many manipulations described in this paper use
conjugations as means for introduction of plasmids into
cells, some them could also be done by plasmid transfor-
mation which would alleviate the need for counter-selec-
tion strategies required for bacterial matings. We,
however, consistently find that conjugations are equally
convenient and more efficient means of plasmid transfer
than transformation.
Methods
Bacterial strains, media and growth conditions
Bacterial strains used in this study are listed in Table 1.
Bacteria were routinely grown at 37°C in Luria Bertani
broth Lennox (LB) [18] or on LB agar purchased from
MO BIO Laboratories, Carlsbad, CA. The sacB-contain-
ing oriR6Kg reporter pR6KT2 was cured by plating plas-
mid-containing cells on yeast extract-tryptone (YT)
sucrose medium containing 10 g/l yeast extract (Difco,
Detroit, MI), 16 g/l tryptone (Fisher Scientific, Fairlawn,
NJ), 16 g/l Bacto agar (Becton, Dickinson and Company,
Sparks, MD) and 15% sucrose (w/v)[19]. Strains contain-
ing temperature-sensitive (TS) plasmid derivatives were
grown at 30°C (permissive temperature) for plasmid
maintenance and 37°C or 42°C (non-permissive tem-
perature) for plasmid curing. Antibiotics were added at
the following concentrations: 100 μg/ml ampicillin
(Amp), 10-15 μg/ml gentamicin (Gm) and 35 μg/ml
kanamycin (Km) for E. coli and S. enterica serovar
Typhimurium harboring plasmids or for selection of
chromosomally-integrated mini-Tn7 elements. Antibio-
tics were purchased from EMD Biosciences, San Diego,
CA (Gm) and Sigma, St. Louis, MO (Amp and Km). For
E. coli strain RHO3, media were supplemented with dia-
minopimelic acid (DAP; LL-, DD-, and meso-isomers;
Table 1 Bacterial strains used in this study
Bacterial
strains
E. coli
Relevant genotype Source or
reference
DB3.1 F
- gyrA462 endA1 glnV44 Δ(sr1-recA) mcrB mrr hsdS20 (rB
- mB
-) ara14 galK2 lacY1 proA2 rpsL20 xyl5 Δleu mtl1 Invitrogen
PIR1 F
- Δ(argF-lac)169 rpoS(Am) robA1 creC510 hsdR514 endA recA1 uidA(ΔMluI)::pir-116 Invitrogen
PIR2 F
- Δ(argF-lac)169 rpoS(Am) robA1 creC510 hsdR514 endA recA1 uidA(ΔMluI)::pir
+ Invitrogen
RHO3 SM10 (lpir)
1 Δasd::FRT ΔaphA::FRT [19]
DH5a F
- j80 lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK
- mK
+) phoA glnV44 [20]
JM108 mcrA recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 Δ(lac-proAB) [21]
MC4100 F
- araD139 Δ(argF-lac)169 flhD5301 Δ(fruK-yeiR)725 (fruA25) relA1 rpsL150 rbsR22 Δ(fimB-fimE)632::IS deoC1 [22,23]
SM10 thi-1 thr-1 leuB26 tonA21 lacY1 supE44 recA integrated RP4-2 Tc
r::Mu aphA
+ (Km
r)
(RP4-2 is RP4 ΔTn1)
[24]
SBr1 DH5a::mini-Tn7-pir
+ This study
SBr2 JM108::mini-Tn7-pir
+ This study
SBr3 MC4100::mini-Tn7-pir
+ This study
SBr4 SM10::mini-Tn7-pir
+ This study
MaH1 DH5a::mini-Tn7-pir-116 This study
MaH2 JM108::mini-Tn7-pir-116 This study
MaH3 MC4100::mini-Tn7-pir-116 This study
MaH4 SM10::mini-Tn7-pir-116 This study
MaH5 DH5a::mini-Tn7-pir-116-FKm This study
RHO4
2 RHO3::mini-Tn7-pir-116-FKm This study
RHO5
2 RHO3::mini-Tn7-pir-116-FRT This study
S. enterica
serovar
Typhimurium
14028S Wild Type ATCC
SDr1 14028S::mini-Tn7-pir
+ This study
SDr2 14028S::mini-Tn7-pir-116 This study
1The pir gene carried by lpir has a truncation that removes the coding region for the carboxy-terminal 30 amino acids of the π protein. Despite this truncation a
lpir lysogen maintains plasmids with at the same copy number as cells carrying a wild-type pir
+ gene [9].
2The pir-116 allele is dominant over the pir gene carried by the lysogenic l phage and leads to increased copy number of oriR6Kg containing plasmids.
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μg/ml for agar plates and 200 μg/ml for broth cultures.
5-bromo-4-chloro-3-indolyl-b-D-glucuronic acid
(XGluc; Gold Biotechnology, St. Louis, MO) was added
to media at a final concentration of 40 μg/ml. Induction
of gene expression from the arabinose operon promoter
(PBAD) was achieved by addition of L-arabinose to media
at a final concentration of 0.5% (w/v).
DNA and genetic methods
Isolation of plasmid DNA
Plasmid DNAs were isolated from E. coli and S. enterica
serovar Typhimurium by using a Fermentas GeneJET
Plasmid MiniPrep Kit (Fermentas, Glen Burnie, MD).
Transposition of mini-Tn7
The respective mini-Tn7 delivery vectors were trans-
formed into E. coli mobilizer strain RHO3 [19]. Conju-
gation of delivery plasmid into E. coli and S. enterica
serovar Typhimurium strains was achieved by biparental
mating using previously described methods [19] with
some minor modifications. Briefly, RHO3 donor and E.
coli and S. enterica serovar Typhimurium recipient cul-
tures were grown overnight at 30°C (pGRG36-based
donor strains) or 37°C (recipient strains) in LB medium
with the appropriate nutritional (DAP) and antibiotic
(Amp) supplements for RHO3 with the mini-Tn7 deliv-
ery vector. One ml of donor and recipient were placed
into separate 1.7 ml microcentrifuge tubes and harvested
by centrifugation in a microcentrifuge for 30 s at
13,400×g and room temperature. Cells were washed
twice in 1 ml LB medium and then re-suspended in 200
μl of LB medium. Equal volumes (25 μl) of each cell
suspension were transferred to a cellulose acetate mem-
brane (13 mm diameter; 0.45 μM pore size; Sartorius
Stedim, Bohemia, NY) sitting on an LB agar plate con-
taining 400 μg/ml DAP and 0.5% arabinose. After over-
night incubation at 30°C, the membrane was transferred
to a microcentrifuge tube containing 1 ml of LB and
cells dislodged by centrifugation in a microfuge for 30 s
at 13,400×g and room temperature. After removing the
membrane, cells were washed twice in 1 mL LB and
then re-suspended in 200 μlo fL Bm e d i u m .T h ee n t i r e
sample was placed on an LB-agar plate with 100 μg/ml
Amp and 0.5% arabinose, and a portion streaked for sin-
gle colonies with an inoculating loop. The plates were
incubated at 30°C overnight or until single colonies
were clearly discernable.
A single purified colony was then used as recipient for
the oriR6Kg reporter pR6KT2. This plasmid was intro-
duced via biparental mating from RHO3 as described
above, except that recipient cells were grown in the pre-
sence of Amp and arabinose and RHO3/pR6KT2 cul-
tures were grown in the presence of Gm and DAP.
After overnight incubation at 30°C mating mixtures
were recovered and plated on LB with 15 μg/ml Gm at
37°C to cure the temperature-sensitive mini-Tn7 deliv-
ery vector and select for pR6KT2. Purified colonies were
patched on LB, LB + Gm and LB + Amp to confirm the
loss of the mini-Tn7 delivery vector (Amp susceptibility)
and presence of pR6KT2 (Gm resistance). After verifica-
tion of mini-Tn7 insertions by PCR, pR6KT2 was cured
by streaking a single colony on YT medium with
sucrose and XGluc, and incubating overnight at 37°C.
Single colonies were patched on LB and LB + Gm plates
to confirm the loss of the plasmid. The pir gene inser-
tions in the resulting strains were then re-confirmed by
PCR and sequencing of the resulting DNA fragments.
When using the mini-Tn7-pir-FKm vectors, the proto-
col for conjugation was as described above for mini-Tn7
delivery without antibiotic selection. Exconjugants were
grown overnight in LB + DAP and arabinose at 30°C,
and Km
r transposon insertions were selected by plating
conjugation mixtures on LB plates with 35 μg/ml Km
followed by incubation at 42°C to cure the delivery plas-
mid. The Km
r marker can optionally be deleted from
the strain with the mini-Tn7-pir-FKm insertion by
transformation with pFLP2 (or any other Flp recombi-
nase-expressing plasmid such as pCP20 [25]), testing
transformants for Km susceptibility and then curing
pFLP2 by plating on sucrose-containing media following
previously described protocols [17].
Confirmation of mini-Tn7-pir insertions
Insertions of mini-Tn7-pir at attTn7 in E. coli and S.
enterica serovar Typhimurium were performed by colony
PCR using DNA in boiling preparation lysates as tem-
plates. These lysates were obtained by transferring sepa-
rate colonies to individual sterile microcentrifuge tubes
containing 30 μl of sterile water and boiling for 10 min.
Using 6 μl of these boiling preparations and Taq DNA
polymerase from New England Biolabs, PCR reactions
were performed in a total volume of 50 μl. Primer pairs
2372 (5’-GATGCTGGTGGCGAAGCTGTC) & 2373 (5’-
GATGACGGTTTGTCACATGGAG) and 2374 (5’-CAG
CAACGACAACATGCACA) & 2375 (5’-AAACCAT
CAGCGCGGAACAA) were used for E. coli and S. enter-
ica serovar Typhimurium, respectively. In each case, the
entire PCR reaction was analyzed on a 1% agarose gel.
Expected PCR fragment sizes are 678 bp for E. coli with-
out a mini-Tn7 insertion and 2,539 bp for derivatives con-
taining mini-Tn7-pir
+ and mini-Tn7-pir-116.F r a g m e n t
sizes for S. enterica serovar Typhimurium without and
with mini-Tn7-pir insertions are 485 bp and 2,345 bp,
respectively. When utilizing mini-Tn7-pir-FKm, the frag-
ment sizes obtained with strains containing pir
+ or pir-116
insertions change by +1,470 bp when the Km
r marker is
present or by +145 bp after its Flp-mediated excision.
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Plasmids used in this study are listed in Table 2. The Gate-
way-compatible mini-Tn7 delivery vector pGRG36GW
was constructed by cloning of a 1,770-bp StuI-XhoIf r a g -
ment from pUC18-mini-Tn7T-Gm-GW [16] between the
SmaIa n dXhoI sites of pGRG36 [11], followed by transfor-
mation into the gyrA462 strain DB3.1.
The pir
+ and pir-116 Gateway donor clones were con-
structed as follows. First, the pir
+ and pir-116 genes
were PCR-amplified from E. coli strain PIR2 (pir
+)a n d
PIR1 (pir-116) chromosomal DNA templates using HiFi
Taq polymerase (Invitrogen) and primers 1333
(5’-TGAGCGTCGCAGAACATTACA) & 1334 (5’-ACC
TGGGTGGACGATATCAC). The resulting 1,264-bp
PCR fragments were cloned into the TA cloning vector
pCR2.1 (Invitrogen) to create pCR2.1pir and pCR2.1pir-
116.N e x t ,attB sequences were attached to the respec-
tive pir gene segments using PCR with primers 1558
(5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTGA
GCGTCGCAGAACATTACA; the attB1 sequence is
underlined) & 1559 (5’-GGGGACCACTTTGTACAA
GAAAGCTGGGTACCTGGGTGGACGATATCAC; the
attB2 sequence is underlined), and pCR2.1-pir and
pCR2.1-pir-116 DNA as templates. This generated
1,323-bp DNA fragments that were recombined into
pDONR221 using Gateway BP clonase reactions which
created pDONR221pir and pDONR221pir-116, respec-
tively. Finally, the inserts from pDONR221pir and
pDONR221pir-116 were transferred to pGRG36GW
using LR Gateway recombination to yield pGRG36pir
and pGRG36pir-116. The pGRG36pir-116-FKm plasmid
was constructed by cloning a 1,470-bp SalIf r a g m e n t
from pFKM4 containing a Km
r gene flanked by Flp
recombinase target (FRT) sites into the XhoIs i t eo f
pGRG36pir-116.
The oriR6Kg reporter pR6KT2 was constructed as fol-
lows. First, the oriR6Kg and oriT regions were PCR-
amplified from pUC18R6KT-mini-Tn7T[ 1 6 ]u s i n gTaq
polymerase (NEB) and primers 2298 (5’-ATTCCCGG
GAGGCCACCACTTCAAGAACTC) & 2299 (5’-TAAT
CCCGGGCTTCCGCTTCCTCGCTCA). The resulting
824-bp amplicon was cloned into
pCR2.1 to create pCR2.1-R6KoriT. Second, the 901-bp
XbaI fragment from non-methylated pPS856 [17] DNA
obtained by isolating the plasmid from dam dcm E. coli
JM110 [21] was ligated with the 6.5-kb SpeIa n dXbaI
digested backbone of pEXKm5 [19] to construct
pEXGm5B. Third, the 915-bp oriR6Kg and oriT XbaI and
Eco53K1 fragment was released from pCR2.1::R6KoriT
and ligated with the 6.2-kb XbaIa n dSmaId i g e s t e d
pEXGm5B backbone to create pR6KTSCE. Finally,
pR6KTSCE was digested with BmgB1 and FspIa n dt h e
5.9-kb backbone was re-circularized to construct the
reporter vector pR6KT2.
All plasmid constructions were verified by restriction
digest and DNA sequence analysis.
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Table 2 Plasmids used in this study
Plasmids Description Reference/Source
pGRG36
a Amp
r; mini-Tn7 delivery vector with TS replicon [11]
pGRG36GW Amp
r,C m
r; Gateway version of pGRG36 This study
pDONR221 Cm
r,K m
r; Gateway cloning vector Invitrogen
pDONR221pir Km
r; pir
+ donor vector This study
pDONR221pir-116 Km
r; pir-116 donor vector This study
pGRG36pir Amp
r; pir
+ delivery vector This study
pGRG36pir-116 Amp
r; pir-116 delivery vector This study
pGRG36pir-116-FKm Amp
r,K m
r; pir-116-FKm delivery vector This study
pFKM4 Amp
r,K m
r; pFKM2 [26] with XbaI and SpeI sites removed and PacI site introduced This study
pR6KT2 Gm
r; Suc
s; oriR6Kg reporter plasmid This study
aThe DNA sequence of pGRG36 can be obtained from GenBank under accession number DQ460223. Sequences of other plasmids constructed in this study are
available from the authors upon request.
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